Overview
Rare hemorrhagic disorder due to a qualitative platelet defect is a broad grouping category on Orphanet (ORPHA:275736) that encompasses a collection of inherited bleeding disorders in which platelets are present in normal or near-normal numbers but do not function properly. Unlike quantitative platelet disorders where platelet counts are reduced, these qualitative defects involve abnormalities in platelet adhesion, activation, aggregation, or secretion. The primary body system affected is the hemostatic (blood clotting) system, leading to a tendency for excessive or prolonged bleeding. Patients with qualitative platelet defects typically present with mucocutaneous bleeding symptoms, which may include easy bruising (ecchymoses), prolonged bleeding from cuts or surgical procedures, nosebleeds (epistaxis), heavy menstrual bleeding (menorrhagia) in women, gum bleeding, and in more severe cases, gastrointestinal bleeding or postpartum hemorrhage. The severity of bleeding can range from mild to life-threatening depending on the specific underlying molecular defect. Symptoms may be present from early childhood or may only become apparent when the hemostatic system is challenged, such as during surgery or trauma. This category includes well-characterized conditions such as Glanzmann thrombasthenia (a defect in platelet aggregation due to GPIIb/IIIa abnormalities), Bernard-Soulier syndrome (a defect in platelet adhesion due to GPIb-IX-V complex abnormalities), and various platelet storage pool deficiencies and signal transduction defects. Treatment is largely supportive and depends on the specific disorder, but may include platelet transfusions for severe bleeding episodes, desmopressin (DDAVP) for mild defects, antifibrinolytic agents such as tranexamic acid, and recombinant activated factor VII (rFVIIa) in refractory cases. Avoidance of antiplatelet medications such as aspirin and NSAIDs is generally recommended. Genetic counseling is important for affected families.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Rare hemorrhagic disorder due to a qualitative platelet defect.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Rare hemorrhagic disorder due to a qualitative platelet defect at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Rare hemorrhagic disorder due to a qualitative platelet defect.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rare hemorrhagic disorder due to a qualitative platelet defect.
Community
No community posts yet. Be the first to share your experience with Rare hemorrhagic disorder due to a qualitative platelet defect.
Start the conversation →Latest news about Rare hemorrhagic disorder due to a qualitative platelet defect
No recent news articles for Rare hemorrhagic disorder due to a qualitative platelet defect.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Rare hemorrhagic disorder due to a qualitative platelet defect
What is Rare hemorrhagic disorder due to a qualitative platelet defect?
Rare hemorrhagic disorder due to a qualitative platelet defect is a broad grouping category on Orphanet (ORPHA:275736) that encompasses a collection of inherited bleeding disorders in which platelets are present in normal or near-normal numbers but do not function properly. Unlike quantitative platelet disorders where platelet counts are reduced, these qualitative defects involve abnormalities in platelet adhesion, activation, aggregation, or secretion. The primary body system affected is the hemostatic (blood clotting) system, leading to a tendency for excessive or prolonged bleeding. Patien